- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Subjects Presenting With Normal or With Ocular Pathology
Total 841 results
-
Topcon Medical Systems, Inc.CompletedSubjects Presenting With Normal or With Ocular PathologyUnited States
-
Topcon Medical Systems, Inc.CompletedSubjects Presenting With Normal EyesUnited States
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With no Known Ocular DiseasesUnited States
-
Shanghai Vinnerna Biosciences Co., Ltd.Sponsor GmbHCompletedSubjects With Liver Function Injury | Normal Liver Function SubjectChina
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
OptovueCompletedNormal Eyes and Eyes With Ocular PathologiesUnited States
-
Rempex Pharmaceuticals (a wholly owned subsidiary...CompletedSubjects With Varying Degrees of Renal Insufficiency and | Subjects With Normal Renal FunctionUnited States
-
Brahms AGRecruitingPatients Presenting With Suspicion of Infection to the EDUnited Kingdom, Spain, Italy, France
-
Hospices Civils de LyonNot yet recruitingNormal Subject | Patient With Pharmaco-resistant EpilepsyFrance
-
Universidade Estadual de Ciências da Saúde de AlagoasCompletedNormal Hearing (76 Subjects) | Subjects With Hearing Loss (15 Subjects)Brazil
-
Asan Medical CenterRecruitingSubjects With Resectable and Localized Gastric Cancer | Subjects With Resectable Esophageal Cancer or Liver Cancer | Subjects With Resectable Liver CancerKorea, Republic of
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedPregnant Women With Foetuses Presenting With Intra-uterine Growth RestrictionFrance
-
AstraZenecaCompletedElderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.Sweden
-
Glaukos CorporationCompletedSubjects With Primary Open-angle Glaucoma (POAG)Armenia
-
Glaukos CorporationCompletedSubjects With Primary Open-angle Glaucoma (POAG)Armenia
-
LG Life SciencesUnknownNormal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar RegionKorea, Republic of
-
Brahms AGCompletedPatients Presenting With Suspicion of Infection to the EDSpain
-
Cairo UniversityUnknownAnterior Maxilla With Deficient Ridge Height and/or Width
-
Sun Yat-sen UniversityRecruiting
-
Heidelberg Engineering GmbHCompletedNormal Eyes of Subjects Without Diabetes Mellitus | Subjects With Diabetes Mellitus Type 2 Without Coexisting DPN | Subjects With Diabetes Mellitus Type 2 With Coexisting Early to Moderate DPN
-
Hôpital Européen MarseilleRecruitingPatients With Acute or Chronic Otoneurological Disorders | Patients Presenting or Having Experienced Dizziness and / or Balance DisordersFrance
-
Glaukos CorporationCompletedSubject With Primary Open-angle Glaucoma (POAG)Armenia
-
Nanostim, Inc.UnknownAtrial Fibrillation With 2 or 3° AV or Bifascicular Bundle Branch (BBB) Block | Normal Sinus Rhythm With 2 or 3° AV or BBB Block | Sinus Bradycardia With Infrequent Pauses or Unexplained Syncope With EP FindingsGermany, Netherlands, Czech Republic
-
National Taiwan University HospitalUnknownPatient With Invasive Cervical Carcinoma | Patient With CIN Lesion | Patient With HPV Infected Patients Without Histopathologic Lesion | Normal Populations.Taiwan
-
DeNova ResearchCompletedSubjects Requesting and Requiring Facial Rejuvenation With Neurotoxins and/or Hyaluronic Acid FillersUnited States
-
University of TorontoCanadian Institutes of Health Research (CIHR)CompletedHealthy Boys With no Emotional, Behavioral or Learning Problems Within a Normal Body WeightCanada
-
University Hospital, BordeauxRecruitingCardiac Rehabilitation Program Following the Management of ACS in Patients Presenting With SCADFrance
-
Alcon ResearchCompletedOcular Inflammation Associated With BlepharaconjunctivitisUnited States
-
AstraZenecaEli Lilly and Company; i3 Drug SafetyCompletedType 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies) | Healthy Subjects (Treated With no Diabetes Therapies)United States
-
LG Life SciencesCompletedNormal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region Who Have Completed the LG-HACL014 StudyKorea, Republic of
-
Mundipharma Research GmbH & Co KGCompletedSubjects With Moderate to Severe, Chronic Nonmalignant Pain
-
Sun Pharma Advanced Research Company LimitedCompletedInflammation and Pain Associated With Ocular SurgeryUnited States
-
Maisonneuve-Rosemont HospitalRecruitingPatients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)Canada
-
Notal Vision Ltd.CompletedAMD Population - Intermediate or Advanced AMD | DR Population- With or Without Diabetic Macular EdemaIsrael
-
Nidek Co. LTD.CompletedCataract | Normal Non-fluency | Aphakic Eye | Eyes With Corneal AbnormalityUnited States
-
Universitat Internacional de CatalunyaCompletedSubjects With Deep Cervical Muscle Strength DeficitSpain
-
BiositeCompletedStroke | Stroke Mimic(Conditions Presenting With Stroke-like Conditions)United States, Canada, Germany, Switzerland, United Kingdom
-
Azienda Ospedaliera Città della Salute e della...CompletedHyponatremia | Hyponatremia With Excess Extracellular Fluid Volume | Hyponatremia With Extracellular Fluid Depletion | Hyponatremia With Normal Extracellular Fluid VolumeItaly
-
Centre Hospitalier Universitaire DijonCompletedPatients With Intellectual Disabilities Without an Obvious Clinical Diagnosis | Patients With Normal Array CGH and Previous Negative Genetic Investigations (WES-solo or WES-trio)France
-
Niguarda HospitalCompletedHealth Subjects With Cardiovascular Risk FactorsItaly
-
Galderma R&DCompletedHealthy Subjects, Male or Female, of 18-60 Years Old, With Phototype I, II or III, Not Pre-treated/Pre-protected SkinFrance
-
Samsung Medical CenterUnknownMacular Hole With High Myopia (Spherical Equivalent ≤ -6.0 Diopters) or, | Large Size Macular Hole (Diameter > 600 Microns) or | Recurred or Failed Macular Hole From Previous Surgery | or Chronic Macular Hole (Symptom Duration > 6 Months)Korea, Republic of
-
ShireCompletedMale Subjects With Chronic ConstipationBelgium, Romania, Poland, Netherlands, Germany, United Kingdom, Bulgaria, Czechia, Denmark, France
-
Silverstein Eye CentersBausch & Lomb Incorporated; Churchhill Communications; Statistics & Data CorporationCompletedTreatment of Ocular Inflammation Associated With Cataract Surgery
-
Ethicon, Inc.TerminatedSubjects Scheduled to Undergo Laparoscopic Radical Resection of Rectal Carcinoma With Preventive IleostomyChina
-
University of OklahomaCompletedHeart Failure With Normal Ejection FractionUnited States
-
MaineHealthHumanNCompletedHeart Failure With Normal Ejection FractionUnited States
-
Heart Center Leipzig - University HospitalCompletedHeart Failure With Normal Ejection FractionGermany
-
Virginia Commonwealth UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Failure With Normal Ejection FractionUnited States